X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

AMTI

Closed

Applied Molecular Transport inc

0.263
0.000 (0.00%)
Last Update: 29 Dec 2023 17:30:00
Yesterday: 0.263
Day's Range: 0.263 - 0.263
Send
When Written:
 
0.32
Applied Molecular Transport Inc (AMT) is a clinical-stage biopharmaceutical company that develops oral biologic therapies to treat autoimmune diseases, inflammatory bowel disease (IBD), and other diseases. AMT's proprietary technology platform, known as the AMT-101 platform, uses a novel approach to deliver biologic drugs to the gut, where they can be absorbed and distributed throughout the body. This approach has the potential to improve the efficacy and safety of biologic drugs, which are currently administered via injections or infusions. AMT is based in South San Francisco, California, and was founded in 2016. The company went public in 2020 and is listed on the NASDAQ exchange under the ticker symbol AMTI.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X